VPS35 Gene (PARK17) Parkinson's Disease Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين VPS35 (PARK17) لمرض باركنسون في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary

الملخص التنفيذي: يوفر اختبار VPS35 الجيني المتطور دقة تشخيصية بنسبة 99.9% عبر معالجة معتمدة من ISO، وخدمة سحب منزلي متميزة، وإرشادات طبية بعد النتائج، مع دعم التحقق المباشر من التأمين عبر واتساب.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Facility License: 9834453 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)

Test Overview

The VPS35 Gene (PARK17) Parkinson's Disease Genetic Test uses Next Generation Sequencing to identify pathogenic mutations in the VPS35 gene, confirming autosomal dominant Parkinson’s disease with high diagnostic precision. يستخدم اختبار الحمض النووي تسلسل الجيل التالي لتحديد الطفرات المسببة لمرض باركنسون الوراثي السائد.

Feature	Our Test (NGS)	Closest Alternative (Sanger Sequencing)
Diagnostic Sensitivity	99.9% for all exon-level variants	~99.0% for targeted regions only
Methodology	Next Generation Sequencing (NGS) – full gene analysis	Single-gene Sanger sequencing of selected exons
Turnaround Time	3 to 4 Weeks	4 to 6 Weeks
Sample Types	Whole Blood, Extracted DNA, or One Drop Blood on FTA Card

Physician Insight & Safety Protocol

“As a neurologist, I understand that genetic testing for Parkinson's disease can evoke anxiety. This test identifies VPS35 mutations to clarify diagnosis and guide family planning, but a positive result does not determine disease severity, and a negative result may not exclude other genetic causes. Always correlate results with clinical evaluation.”

— Dr. PRABHAKAR REDDY, DHA License: 61713011

⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Genetic test results inform long-term management, not immediate drug changes.

Safety Exclusion Criteria & Emergency Signs

Exclusion Criteria: Recent allogeneic hematopoietic stem cell transplant (may interfere with DNA analysis); inability to provide informed consent; severe psychiatric comorbidity requiring stabilization before genetic testing.
ER Red Flags (seek immediate care): Rapid worsening of parkinsonian symptoms, signs of neuroleptic malignant syndrome (high fever, stiffness, altered consciousness), suicidal ideation or psychosis following result disclosure.

Patient FAQ & Clinical Guidance

ما هو تحليل جين VPS35 (PARK17)؟

This test detects VPS35 gene mutations causing autosomal dominant Parkinson's disease for diagnosis and family risk assessment. It analyzes DNA using Genetic Test is recommended for individuals with early-onset Parkinson's or a family history of the disease, guiding personalized treatment and family planning decisions. يوصى به للأشخاص الذين لديهم تاريخ عائلي للمرض.

كم المدة اللازمة لظهور النتائج؟

Results are typically available within 3 to 4 weeks from sample receipt, utilizing advanced NGS technology. This turnaround time includes library preparation, sequencing, bioinformatics analysis, and clinical interpretation by molecular geneticists. Expedited reporting may be possible upon request for urgent clinical scenarios. تظهر النتائج خلال 3 إلى 4 أسابيع باستخدام التقنيات الحديثة.

هل يغطي التأمين تكلفة هذا التحليل؟

Direct billing verification is available via WhatsApp; many UAE insurers cover genetic testing when medically necessary. We assist with pre-authorization by providing the requisition form and clinical notes. Contact our billing team at +971 54 548 8731 for a free benefits check. نتحقق من تغطية التأمين مباشرة عبر واتساب.

This test adheres to UAE Federal Decree-Law No. 41 of 2024 (Art. 87) on medical liability, the 2026 Consumer Data Security (CDS) Law for minors, and the UAE Personal Data Protection Law (PDPL). All samples are processed under ISO 9001:2015 quality management (Cert: INT/EGQ/2509DA/3139) at laboratory license 9834453. Genetic counselling is provided pre- and post- in compliance with DHA guidelines.

دعم ثنائي اللغة متاح